Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Zh. Yu. Chefranova"'
Autor:
Sergey S. Markin, E. A. Ponomarenko, Yu. A Romashova, T. O. Pleshakova, S. V. Ivanov, V. V. Beregovykh, S. L. Konstantinov, G. I. Stryabkova, Zh. Yu. Chefranova, Y. A. Lykov, I. M. Karamova, A. G. Koledinskii, K. M. Shestakova, P. A. Markin, N. E. Moskaleva, S. A. Appolonova
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-17 (2024)
Abstract Myocardial infarction is a major cause of morbidity and mortality worldwide. Metabolomic investigations may be useful for understanding the pathogenesis of ST-segment elevation myocardial infarction (STEMI). STEMI patients were comprehensive
Externí odkaz:
https://doaj.org/article/238eddc3e8744ef19bc2ab2b280bea19
Autor:
D. R. Khasanova, A. A. Yakupova, P. R. Kamchatnov, Zh. Yu. Chefranova, E. I. Bogdanov, P. I Pilipenko, N. M. Khasanova
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 16, Iss 1, Pp 24-32 (2024)
Objective: to evaluate the efficacy and safety of the Prospecta drug in the treatment of cognitive impairment (CI) in patients with ischemic stroke (IS) in the carotid vascular territory.Material and methods. The double-blind, placebo-controlled, ran
Externí odkaz:
https://doaj.org/article/04da149ee1ab4636a33681d1ebb415d2
Autor:
S. S. Markin, E. A. Ponomarenko, Yu. A. Romashova, T. O. Pleshakova, S. V. Ivanov, F. N. Bedretdinov, S. L. Konstantinov, A. A. Nizov, A. G. Koledinskii, A. I. Girivenko, K. M. Shestakova, P. A. Markin, N. E. Moskaleva, M. V. Kozhevnikova, Zh. Yu. Chefranova, S. A. Appolonova
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Cardiovascular disease (CVD) represents one of the main causes of mortality worldwide and nearly a half of it is related to ischemic heart disease (IHD). The article represents a comprehensive study on the diagnostics of IHD through the targ
Externí odkaz:
https://doaj.org/article/87f6a3e5d3ef44cea37af3a5a07f2718
Autor:
S. L. Konstantinov, G. I. Stryabkova, A. I. Basarab, V. N. Kravchuk, I. V. Kаzhanov, S. V. Ivanov, Zh. Yu. Chefranova, S. S. Markin
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 19, Iss 5, Pp 495-501 (2023)
A case report of double thrombolytic therapy with non-immunogenic staphylokinase at a dose of 15 mg bolus over 15 s in a patient with a high-risk massive pulmonary embolism (PE) in the early postoperative period due to femoral wound is described. Aft
Externí odkaz:
https://doaj.org/article/00a80b5d525a478184b93f381c75a380
Autor:
V. A. Parfenov, E. I. Bogdanov, V. B. Laskov, N. S. Makarov, N. V. Pisova, E. A. Salina, Zh. Yu. Chefranova, L. V. Chichanovskaya
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 13, Iss 6, Pp 14-22 (2021)
Prolonged release tolperisone hydrochloride 450 mg (PRTH 450) is a dosage form that is convenient for patients, since it reduces the frequency of drug administration per day: from three immediate release tablets of 150 mg (TH 150) to one tablet of PR
Externí odkaz:
https://doaj.org/article/a6c78e80f2b44eb3bf5ef37af1136e05
Autor:
L. V. Shekhovtsova, O. А. Osipova, Zh. Yu. Chefranova, I. B. Kovalenko, Yu. A. Lykov, I. V. Avdeeva
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 19, Iss 5 (2020)
Aim. To compare the effect of long-term therapy with mineralocorticoid receptor antagonists (MCRA) on markers of electrophysiological instability in patients with heart failure with mid-range ejection fraction (HFmrEF) after ST-segment elevation acut
Externí odkaz:
https://doaj.org/article/6a4bbf31d9794468954e70ae5873b322
Autor:
O. A. Osipova, E. V. Gosteva, Zh. Yu. Chefranova, N. I. Zhernakova, Yu. A. Lykov, I. V. Avdeeva
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 19, Iss 5 (2020)
Aim. To assess the dynamics of collagen metabolism markers during.Material and methods. This open-label, controlled, age-randomized therapy in older patients with heart failure with mid-range ejection study included 162 patients with HFmrEF. Group 1
Externí odkaz:
https://doaj.org/article/bff244836da84c15aa48fa6194aeac44
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 7, Iss 1S, Pp 54-59 (2015)
Objective: to study the specific features of epilepsy in children and adolescents with brain tumors and to define the optimal tactics of management and antiepileptic therapy after surgical treatment. Patients and methods. Sixty-one patients aged 5 mo
Externí odkaz:
https://doaj.org/article/59a35ecb07204bd3b91325f3f9b1e02a
Autor:
I. V. Avdeeva, I. B. Kovalenko, L. V. Shekhovtsova, Yu. A. Lykov, O. А. Osipova, Zh. Yu. Chefranova
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 19, Iss 5 (2020)
Aim. To compare the effect of long-term therapy with mineralocorticoid receptor antagonists (MCRA) on markers of electrophysiological instability in patients with heart failure with mid-range ejection fraction (HFmrEF) after ST-segment elevation acut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::854934ab62c5ba7429389bd0a4f7b3fd
https://cardiovascular.elpub.ru/jour/article/view/2652
https://cardiovascular.elpub.ru/jour/article/view/2652
Publikováno v:
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 121:127
To study the possibility of using the polypeptide drug cortexin for the treatment of cognitive, emotional and behavioral disorders in children and adolescents with epilepsy and to assess the efficacy and safety of the drug in this group of patients.E
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f18d44a64dd9422d5b320090bff478bc
https://doi.org/10.17116/jnevro2021121031127
https://doi.org/10.17116/jnevro2021121031127